Accesso pubblico

Articoli con mandati relativi all'accesso pubblico - Lawrence LeiterUlteriori informazioni

Non disponibili pubblicamente: 18

Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset …

MS Sabatine, LA Leiter, SD Wiviott, RP Giugliano, P Deedwania, ...

The lancet Diabetes & endocrinology 5 (12), 941-950, 2017

Mandati: National Institute for Health Research, UK

Controlla

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy

SS Daskalopoulou, NA Khan, RR Quinn, M Ruzicka, DW McKay, ...

Canadian Journal of Cardiology 28 (3), 270-287, 2012

Mandati: Heart and Stroke Foundation of Canada

Controlla

Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials

S Verma, ME Farkouh, B Yanagawa, DH Fitchett, MR Ahsan, M Ruel, ...

The lancet Diabetes & endocrinology 1 (4), 317-328, 2013

Mandati: Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada

Controlla

Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome

GG Schwartz, AG Olsson, CM Ballantyne, PJ Barter, IM Holme, D Kallend, ...

American heart journal 158 (6), 896-901. e3, 2009

Mandati: US National Institutes of Health

Controlla

Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial

T Cukierman-Yaffe, HC Gerstein, HM Colhoun, R Diaz, LE García-Pérez, ...

The Lancet Neurology 19 (7), 582-590, 2020

Mandati: UK Medical Research Council, Wellcome Trust

Controlla

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy

DM Rabi, SS Daskalopoulou, RS Padwal, NA Khan, SA Grover, ...

Canadian Journal of Cardiology 27 (4), 415-433. e2, 2011

Mandati: Heart and Stroke Foundation of Canada

Controlla

Cardiovascular risk factors and in-hospital mortality in acute coronary syndromes: insights from the Canadian global registry of acute coronary events

JY Wang, SG Goodman, I Saltzman, GC Wong, T Huynh, JP Dery, ...

Canadian Journal of Cardiology 31 (12), 1455-1461, 2015

Mandati: Heart and Stroke Foundation of Canada

Controlla

Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics

E Lonn, J Bosch, J Pogue, A Avezum, I Chazova, A Dans, R Diaz, ...

Canadian Journal of Cardiology 32 (3), 311-318, 2016

Mandati: Canadian Institutes of Health Research

Controlla

Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial

HS Bajaj, HC Gerstein, P Rao-Melacini, J Basile, H Colhoun, I Conget, ...

The lancet Diabetes & endocrinology 9 (8), 484-490, 2021

Mandati: UK Medical Research Council

Controlla

Blood pressure management in adults with type 2 diabetes: insights from the diabetes mellitus status in Canada (DM-SCAN) survey

J Grenier, SG Goodman, LA Leiter, A Langer, H Teoh, DL Bhatt, ...

Canadian Journal of Diabetes 42 (2), 130-137, 2018

Mandati: Heart and Stroke Foundation of Canada

Controlla

Cardiac and inflammatory biomarkers are associated with worsening renal outcomes in patients with type 2 diabetes mellitus: observations from SAVOR-TIMI 53

TA Zelniker, DA Morrow, O Mosenzon, Y Gurmu, K Im, A Cahn, I Raz, ...

Clinical chemistry 65 (6), 781-790, 2019

Mandati: German Research Foundation

Controlla

Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?

A Sharma, H Aziz, S Verma, BL Abramson, R Choi, GL Chua, ...

Current Opinion in Cardiology 36 (5), 672-681, 2021

Mandati: Canadian Institutes of Health Research, Fonds de recherche du Québec - Santé

Controlla

Association of high-density lipoprotein particle concentration with cardiovascular risk following acute coronary syndrome: A case-cohort analysis of the dal-Outcomes trial

T Salahuddin, J Kittelson, JC Tardif, PK Shah, AG Olsson, SJ Nicholls, ...

American Heart Journal 221, 60-66, 2020

Mandati: US National Institutes of Health, American Heart Association, National …

Controlla

Glycemic control and cardiovascular risk factor management in adults with type 2 diabetes with and without chronic kidney disease before sodium-glucose cotransporter protein 2 …

H Nouraei, LA Leiter, MK Tan, A Langer, H Teoh, AYY Cheng, R Wald, ...

Canadian Journal of Diabetes 45 (8), 743-749, 2021

Mandati: Heart and Stroke Foundation of Canada

Controlla

Self-monitoring of blood glucose in type 2 diabetes: Results of the 2011 Survey on Living with Chronic Diseases in Canada.

CB Agborsangaya, C Robitaille, P Dunbar, MF Langlois, LA Leiter, S Dai, ...

Health Reports 24 (6), 2013

Mandati: Canadian Institutes of Health Research

Controlla

Cardiovascular risk factor management in patients with diabetes: Does management differ with disease duration?

S Lo, LA Leiter, A Langer, M Tan, L Goldin, S Harris, JF Yale, JM Ekoe, ...

Journal of Diabetes and its Complications 35 (10), 107997, 2021